Valuation: Alcon Inc.

Capitalization 30.84B 26.2B 23.98B 22.63B 42.22B 2,913B 42.59B 284B 111B 1,399B 116B 113B 4,830B P/E ratio 2026 *
28.9x
P/E ratio 2027 * 22.8x
Enterprise value 33.42B 28.39B 25.99B 24.53B 45.75B 3,156B 46.15B 308B 120B 1,516B 125B 123B 5,234B EV / Sales 2026 *
3x
EV / Sales 2027 * 2.73x
Free-Float
97.35%
Yield 2026 *
0.55%
Yield 2027 * 0.64%
1 day-0.57%
1 week-15.75%
Current month-16.18%
1 month-20.91%
3 months-18.83%
6 months-20.91%
Current year-22.88%
1 week 47.8
Extreme 47.8
58.22
1 month 47.8
Extreme 47.8
64.08
Current year 47.8
Extreme 47.8
68.34
1 year 47.8
Extreme 47.8
80.96
3 years 47.8
Extreme 47.8
87
5 years 47.8
Extreme 47.8
87
10 years 38.62
Extreme 38.625
87
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5d. change 1-year change 3-years change Capi.($)
-0.57%-15.75%-39.05%-31.60% 30.84B
-3.00%-4.10%-33.30%-10.53% 92.89B
-0.52%-3.15%-29.44%-39.21% 11.71B
+0.12%-4.99% - - 9B
-3.11%-4.79%+75.31%+731.11% 2.89B
+0.85%-0.83%-4.92%-53.71% 1.87B
-0.38%+3.21%-31.22%-15.41% 1.09B
-0.98%-5.61% - - 783M
-0.68%-1.36%+14.88%-44.88% 762M
+0.88%+2.15%-17.37%-28.09% 705M
Average -0.76%-2.98%-8.14%+63.46% 15.25B
Weighted average by Cap. -2.08%-7.07%-31.30%-3.29%

Financials

2026 *2027 *
Net sales 11.13B 9.46B 8.65B 8.17B 15.24B 1,051B 15.37B 103B 40.02B 505B 41.76B 40.88B 1,743B 11.83B 10.05B 9.2B 8.68B 16.2B 1,117B 16.34B 109B 42.54B 537B 44.39B 43.46B 1,853B
Net income 1.1B 935M 855M 807M 1.51B 104B 1.52B 10.15B 3.96B 49.91B 4.13B 4.04B 172B 1.39B 1.18B 1.08B 1.02B 1.9B 131B 1.92B 12.8B 4.99B 62.98B 5.21B 5.1B 217B
Net Debt 2.58B 2.19B 2.01B 1.89B 3.53B 244B 3.56B 23.78B 9.27B 117B 9.67B 9.47B 404B 1.48B 1.26B 1.15B 1.09B 2.03B 140B 2.04B 13.65B 5.32B 67.15B 5.55B 5.44B 232B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
11/05/26 48.76 CHF -0.83% 2,464,221
08/05/26 49.17 CHF -2.29% 2,362,644
07/05/26 50.32 CHF -2.93% 4,093,790
06/05/26 51.84 CHF -10.96% 6,938,472
05/05/26 58.22 CHF +0.52% 962,921
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
63.24USD
Average target price
97.17USD
Spread / Average Target
+53.65%

Quarterly revenue - Rate of surprise